POM-V Prescription Required Companion Animal

Antirobe 75 mg Capsules for Dogs

Active ingredient: Clindamycin

Form

Capsule

Species

Dogs

Manufacturer

Zoetis UK Limited

VMD MA No.

42058/5156

What it's used for

Antirobe Capsules 75 mg are indicated for use in dogs as follows: For the treatment of infected wounds and abscesses, and infected mouth cavity and dental...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Clindamycin

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Antirobe 75 mg Capsules for Dogs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 18 Mar 2026.

Antirobe Capsules 75 mg are indicated for use in dogs as follows:
For the treatment of infected wounds and abscesses, and infected mouth
cavity and dental infections, caused by or associated with
spp., Streptococcus spp. (except ),
Fusobacterium necrophorum, and . To help provide
antimicrobial cover during dental procedures.
For the treatment of superficial pyoderma associated with
intermedius.
For the treatment of osteomyelitis, caused by .
Before Antirobe therapy is initiated, the involved pathogens should be
identified and sensitivity to clindamycin established.

For oral administration only.
1. For the treatment of infected wounds and abscesses, and infected mouth
cavity and dental infections in dogs and cats, administer either:
•

Revised: November 2024
AN: 01545/2024
•
If no clinical response is seen within 4 days, redetermine the diagnosis. To
help provide antimicrobial cover during dental procedures, a 10 day course is
recommended. This should be initiated five days before dental therapy and
continued for five days thereafter. In dogs, treatment may be extended to a
maximum of 28 days based on clinical judgement.
2. For the treatment of superficial pyoderma in dogs, administer either:
•
•
Therapy of canine superficial pyoderma is usually recommended for 21 days,
with extension of therapy based on clinical judgement.
3. For the treatment of osteomyelitis in dogs, administer:
•
If no clinical response is seen within 14 days, the treatment should be
stopped and the diagnosis redetermined.

Contra-indicated in animals which are hypersensitive to preparations
containing clindamycin or lincomycin.
Do not administer to rabbits, hamsters, guinea pigs, chinchillas, horses or
ruminants because ingestion of clindamycin by these species may result in
severe gastro-intestinal disturbance.

Vomiting and diarrhoea have occasionally been observed.
Antirobe sometimes causes the overgrowth of non-sensitive organisms such
as resistant clostridia and yeasts. In cases of superinfection, appropriate
measures must be taken according to the clinical situation.

None.

Revised: November 2024
AN: 01545/2024

i. Special precautions for use in animals
Clindamycin and erythromycin show parallel resistance. Partial
cross-resistance has been demonstrated between clindamycin,
erythromycin and other macrolides antibiotics.
During prolonged therapy of one month or greater, periodic liver and
kidney function tests and blood counts should be performed.
Animals with severe renal and/or very severe hepatic disturbances
accompanied by severe metabolic aberrations should be dosed with
caution and should be monitored by serum examination during high-
dose clindamycin therapy.
ii. Special precautions to be taken by the person administering the
veterinary medicinal product to animals
Wash hands after handling capsules.

Clindamycin hydrochloride has been shown to have neuromuscular blocking
properties that may enhance the action of other neuromuscular blocking
agents. Antirobe Capsules should be used with caution in animals receiving
such agents.
Clindamycin should not be used concomitantly with chloramphenicol or
macrolides as they antagonise each other at their site of action at the 50S
ribosomal sub-unit.

Do not store above 25°C.

Not applicable.
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.